Clinical Trial Update: Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation [Phase 4]

View source ↗

Summary

A Phase 4 study is evaluating the long-term effectiveness of Jack Jumper Ant venom immunotherapy for venom allergy and is currently recruiting. The sponsor is M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venom Allergy

Drugs mentioned

• Jack Jumper Ant venom immunotherapy (venom immunotherapy)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Allergy, Immunotherapy | Phase 4 | Status: RECRUITING